Abstract
This study, carried out on 9 nonfunctioning pituitary adenomas, was undertaken in order to evaluate the ability of these tumors to synthesize and release gonadotropins and/or free a-subunit (a-SU) of glycoproteins. The morphological study included electron microscopy and immunofluorescence analysis while hormone release was evaluated by the reverse hemolytic plaque assay (RHPA) and measurements in culture media. By electron microscopy in all tumors (6 null cell adenomas and 3 oncocytomas), it was possible to identify rough endoplasmic reticulum, Golgi apparatus and secretory granules. By immunofluorescence, 5 of 6 tumors were immunoreactive for one or more gonadotropin subunits; in particular, 5 adenomas were positive for α-SU and LH-β, and 3 for FSH-β. By the RHPA, about 1% of cells obtained from one single tumor formed plaques for LH-α and β-SU while the remaining tumors were negative. Similarly, the study of media concentrations of LH, FSH and α-SU in 2 h culture revealed very low amounts of released hormones. In these experimental conditions no modification was observed after the addition of stimulatory agents such as TRH, GnRH and VIP. The present study clearly indicates that although the large majority of nonfunctioning tumors are positive for gonadotropins their secretory capacity is very low in both basal and stimulated conditions.
Similar content being viewed by others
References
Crichton M., Christy N.P., Damon A. Host factors in “cromophobe” adenoma of the anterior pituitary: a retrospective study of 464 patients. Metabolism 30:248, 1981.
Mac Farlane I.A., Beardwell CG., Shalet S.M., Ainslie G., Rankin E. Glycoprotein hormone α-subunit secretion in patients with pituitary adenomas: influence of TRH, LRH and bromocriptine. Acta Endocrinol. (Copenh.) 99:487, 1982.
Ridgway E.C., Klibansky A., Landenson P.W., Clemmons D., Beitins I.Z., Mc Arthur J.W., Martorana M.A., Zervas N.T. Pure alpha-secreting pituitary adenomas. N. Engl. J. Med. 304:1254, 1981.
Ridgway E.C. Glycoprotein hormone production by pituitary tumors. In: Black PMcL, (Ed.), Secretory tumors of the pituitary gland. Raven Press, New York, 1984, p.343.
Snyder P.J. Gonadotroph cell adenomas of the pituitary. Endocr. Rev. 6:552, 1985.
Faglia G., Spada A., Beck-Peccoz P., Persani L, Ambrosi B., Colombo P. Clinically nonfunctioning pituitary adenomas: advances and perspectives. In: Faglia G., Beck Peccoz P., Ambrosi B., Travaglini P., Spada A. (Eds.), Pituitary adenomas; new trends in basic and clinical research. International Congress Series 961. Excerpta Medica, Amsterdam, 1991, p.373.
Black P.M., Hau D.W., Klibanski A. Hormone production in clinically nonfunctioning pituitary adenomas. J. Neurosug. 66:244, 1987.
Surmount D.W.A., Winslow C.L.J., Loizou M., White M.C, Adams E.F., Mashiter K. Gonadotropin and alpha subunit secretion by human functionless pituitary adenomas in cell culture; long term effects of luteinizing hormone releasing hormone and thyrotropin releasing hormone. Clin. Endocrinol. (Oxf.) 19:325, 1983.
Asa S.L., Gerrie B.M., Singer W., Horvath E., Kovacs K., Smyth H.S. Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas. J. Clin. Endocrinol. Metab. 62:1011, 1986.
Yamada S., Asa S.L., Kovacs K., Muller P., Smyth H.S. Analysis of hormone secretion by clinically nonfunctioning human pituitary adenomas using the reverse hemolytic plaque assay. J. Clin. Endocrinol. Metab. 68: 73, 1989.
Kwekkeboom D.J., De Jong F.H., Lamberts S.W.J. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro; relation to sex and effects of thyrotropin-re-leasing hormone, gonadotropin-releasing hormone and bromocriptine. J. Clin. Endocrinol. Metab. 68:1128, 1989.
Mashiter K., Adams E., Van Noorden S. Secretion of LH, FSH and PRL shown by cell culture and immunocytochemistry of human functionless pituitary adenomas. Clin. Endocrinol. (Oxf.) 15:103, 1981.
Jameson J.L., Klibanski A., Black P.M., Zervas N.T., Lindell C.M., Hsu D.W., Ridgway E.C., Habener J.F. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas. J.Clin. Invest. 80:1472, 1987.
Ikuyama S., Nawata H., Kato K., Karashima T., Ibayashi H., Nagkagaki H. Specific somatostatin receptors on human pituitary adenoma cell membranes. J. Clin. Endocrinol. Metab. 61:666, 1985.
Bevan J.S., Burke C.W. Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptine. Clin. Endocrinol. (Oxf.) 25:561, 1986.
Le Dafniet M., Grouselle D., Li J.Y., Kujas M., Bression D., Barret A., Texier-Vidal A., Peillon F. Evidence of thyrotropin-releasing hormone (TRH) and TRH-binding sites in human non-secreting pituitary adenomas. J. Clin. Endocrinol. Metab. 65:1014, 1987.
Spada A., Reza-Elahi F., Lania A., Gil del Alamo P., Bassetti M., Faglia G. Hypothalamic peptides modulate cytosolic free Ca++ levels and adenylyl cyclase activity in human nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab. 73:913, 1991.
Bassetti M., Spada A., Arosio M., Vallar L, Brina M., Giannattasio G. Morphological studies on mixed growth hormone (GH)- and prolactin (PRL) secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule. J. Clin. Endocrinol. Metab. 62:1093, 1986.
Rosa P., Bassetti M., Weiss U., Huttner W.B. Widespread occurrence of secretogranin/ cromo-granin in the matrix of secretory granules of en-docrinologically silent pituitary adenomas. J. Hystochem. Cytochem. 40:523, 1992.
Bassetti M., Brina M., Spada A., Giannattasio G. Somatomammotrophic cells in GH-secreting and PRL-secreting human pituitary adenomas. J. Endocrinol. Invest. 12:705, 1989.
Spada A., Sartorio A., Bassetti M., Pezzo G., Giannattasio G. In vitro effect of dopamine on growth hormone (GH) release from human GH secreting pituitary adenomas. J. Clin. Endocrinol. Metab. 55:734, 1982.
Neill J.D., Frawley L.S. Detection of hormone release from individual cells in mixed populations using a reverse hemolytic plaque assay. Endocrinology 112:1135, 1983.
Lloyd R.V., Anagnostou D., Cano M., Barkan A.L., Chandler W.F. Analysis of mammosomatotropic cells in normal and neoplastic human pituitary tissues by the reverse hemolytic plaque assay and immunocytochemistry. J. Clin. Endocrinol. Metab. 66:1103, 1988.
Luque E.H., Munoz de Toro M., Smith P.F., Neill J.D. Subpopulations of lactotropes detected with the reverse hemolytic plaque assay show differential responsiveness to dopamine. Endocrinology 118:2120, 1986.
Hoeffler J.P., Hicks S.A., Frawley L.S. Existence of somatotrope subpopulations which are differentially responsive to insulin-like growth factor I and somatostatin. Endocrinology 120:1936, 1987.
Hofland L.J., van Koetsveld M., van Vroonhoven C.C.J., Stefanko S.Z., Lamberts S.W.J. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201–995, GH-releas-ing hormone and Thyrotropin-Releasing Hormone. J. Clin. Endocrinol. Metab. 68:613, 1989.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saccomanno, K., del Alamo, P.G., Bassetti, M. et al. In vitro detection of glycoprotein production and secretion by human nonfunctioning pituitary adenomas. J Endocrinol Invest 16, 109–115 (1993). https://doi.org/10.1007/BF03347659
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347659